文献检索文档翻译深度研究

邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

不再提醒

插件&应用

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

高级版

套餐订阅购买积分包

AI 工具

文献检索文档翻译深度研究

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2025

Editorial: Drug resistance in breast cancer - mechanisms and approaches to overcome chemoresistance.

作者信息

Raman Dayanidhi, Cimpean Anca Maria, De Miglio Maria Rosaria

机构信息

Department of Cell and Cancer Biology, University of Toledo, Toledo OH, United States.

Department of Microscopic Morphology/Histology, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.

出版信息

Front Oncol. 2023 Jan 4;12:1080684. doi: 10.3389/fonc.2022.1080684. eCollection 2022.

DOI:10.3389/fonc.2022.1080684

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9847496/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6527/9847496/82969c30243d/fonc-12-1080684-g001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6527/9847496/82969c30243d/fonc-12-1080684-g001.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6527/9847496/82969c30243d/fonc-12-1080684-g001.jpg

相似文献

[1]

Editorial: Drug resistance in breast cancer - mechanisms and approaches to overcome chemoresistance.

Front Oncol. 2023-1-4

[2]

Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.

Cancer Lett. 2021-12-28

[3]

Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer.

Cells. 2020-6-21

[4]

Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies.

Front Oncol. 2021-7-1

[5]

Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer.

Oncotarget. 2017-5-23

[6]

Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer.

Stem Cell Res Ther. 2017-7-27

[7]

Long non-coding RNA mediated drug resistance in breast cancer.

Drug Resist Updat. 2022-7

[8]

The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer.

Oncotarget. 2017-11-8

[9]

An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.

Future Oncol. 2021-11

[10]

The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.

Expert Opin Drug Metab Toxicol. 2021-3

引用本文的文献

[1]

Identification and characterization of cuproptosis related gene subtypes through multi-omics bioinformatics analysis in breast cancer.

Discov Oncol. 2025-2-13

[2]

A promising target for breast cancer: B7-H3.

BMC Cancer. 2024-2-7

本文引用的文献

[1]

Endocrine Therapy-related Endocrinopathies-Biology, Prevalence and Implications for the Management of Breast Cancer.

Oncol Hematol Rev. 2020

[2]

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021-5

[3]

Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells.

PLoS One. 2021

[4]

Olaparib monotherapy as primary treatment in unselected triple negative breast cancer.

Ann Oncol. 2021-2

[5]

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5).

Ann Oncol. 2020-12

[6]

DNA damage response and resistance of cancer stem cells.

Cancer Lett. 2020-1-20

[7]

Immunotherapy and targeted therapy combinations in metastatic breast cancer.

Lancet Oncol. 2019-3

[8]

Functional miRNAs in breast cancer drug resistance.

Onco Targets Ther. 2018-3-19

[9]

Targeted therapies in breast cancer: New challenges to fight against resistance.

World J Clin Oncol. 2017-4-10

[10]

A novel method to limit breast cancer stem cells in states of quiescence, proliferation or differentiation: Use of gel stress in combination with stem cell growth factors.

Oncol Lett. 2016-8

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

推荐工具

医学文档翻译智能文献检索